๐ŸŒ ORIGIN Phase III trial

organization

ORIGIN Phase III trial is a large international clinical study monitoring the effects of insulin glargine and omega-3 fatty acids on cardiovascular outcomes in people at high risk of diabetes or cardiovascular disease.

1
Signals
1
Articles

Linked Signals

SignalStatusLensRoleConfidenceLast Seen
Common cold sore virus may reprogram the brain's immune defenses expired Health involved 100%